Monsanto and Evogene Extend Collaboration on Yield and Stress Research29/11/2011
Collaboration Adds Evogene's Gene2ProductTM Computational Technologies
ST. LOUIS, MO, USA and REHOVOT, ISRAEL (November 29, 2011) – Monsanto Company (NYSE:MON) and Evogene Ltd. (TASE: EVGN) announced today a one-year extension to their five-year research and development collaboration focused on identifying key plant genes related to yield, environmental stress and fertilizer utilization in corn, soybean, cotton and canola. The companies recently announced the successful completion of the collaboration’s third year.
The collaboration’s gene discovery activities to date have been based on Evogene’s ATHLETETM computational technology. As part of the extension, Evogene will add its Gene2ProductTM computational technologies to its gene discovery program, offering an additional approach for enhancing trait efficacy and the development of candidate genes identified under the collaboration.
Ofer Haviv, Evogene's President and CEO stated, "We are delighted by this extension of our joint work with Monsanto and in particular with the addition of our Gene2Product computational technologies. We expect that by bringing together Monsanto's development expertise and these new Evogene technologies, in addition to those already utilized in the collaboration, the companies will be able to further address some of the key challenges that the seed industry is facing in the discovery and development process for biotechnology products in agriculture.”
“Continued agricultural innovation is the key to meeting growing global demand, which is why productive collaborations like this one are critical,” added Bob Reiter, Vice President and Global Lead of Biotechnology for Monsanto Company. "By combining Evogene’s innovative gene discovery technologies with Monsanto’s trait development expertise, we’ll ultimately be able to better deliver products to help farmers increase their productivity.”
Additional terms of the collaboration include:
- Evogene will continue to provide Monsanto with candidate genes discovered by Evogene’s computational technologies that are predicted to improve yield, fertilizer utilization and a plant’s reaction to environmental stress. The genes will be validated by Evogene in model plants.
- Monsanto receives exclusive license rights to such candidate genes delivered by Evogene for use in corn, soybean, canola, and cotton.
- As stated above, Evogene will now begin to apply its Gene2ProductTM computational technologies to optimize trait efficacy and the product development process. Evogene will receive additional research payments related to this addition to the collaboration.
- Successful candidate genes that emerge from the collaboration will be commercialized by Monsanto through its branded seed and trait licensing businesses, with Evogene entitled to receive both development milestone payments and royalties.
As part of the original agreement, Monsanto agreed, via a put option exercisable by Evogene, to invest $12 million toward additional equity in Evogene. This arrangement remains in place under a new put option that is exercisable at $12 per share at a later date.
About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com. Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at www.monsantoblog.com, or subscribe to our News Release RSS Feed.
Evogene is a world leading developer of improved plant traits, such as yield and drought tolerance, for a wide diversity of key crops through the use of plant genomics. The company focuses on utilizing its proprietary computational genomic technologies to provide a complete solution for plant trait improvement through combining state of the art biotechnology and advanced breeding methods. These technologies include ATHLETETM for gene discovery; Gene2ProductTM for improving trait efficacy and probability of successful development of biotechnology seed products; and EvoBreedTM for breeding enhancement. Evogene's plant genomics capabilities combine high throughput plant validation systems, field experiments and proprietary genomic data creation. Evogene is collaborating with world leading seed companies to introduce its improved plant traits into key commercial crops under milestone and royalty bearing agreements. Evogene's headquarters are in Rehovot, Israel, and its stock is traded on the Tel Aviv Stock Exchange (TASE: EVGN). For additional information, please visit Evogene’s website at www.evogene.com.
Press releases for 2011
- Evogene Expands Biofuel Activity in Brazil with SLC Agricola
- Monsanto and Evogene Extend Collaboration on Yield and Stress Research
- Evogene Reports Third Quarter 2011 Financial Results
- DuPont and Evogene Enter Multiyear Collaboration for Soybean Rust Resistance
- Evogene to present at the 'WATEC ISRAEL 2011' International conference in Tel-Aviv on November 15 2011
- Bayer CropScience and Evogene Achieve Milestone in Wheat Genetics Research
- Evogene and Monsanto Mark Completion of Third Year of Five-Year Collaboration
- Evogene Reports Second Quarter 2011 Financial Results
- Evogene To Publish a Scientific Paper: Sequencing of Melon Fruit
- Evogene Announces Exercise of the Company's Series 2 Warrants
- Evogene presents at the 'Innovation and Entrepreneurship' Kinneret Panel in Kinneret College
- Evogene Reports First Quarter 2011 Financial Results
- Evogene presents at the 'Genomics in Business 2011' congress in Amsterdam, Netherlands, April 3-5, 2011
- Evogene and Zeraim Gedera Extend Collaboration for Development of Salt Tolerant Tomato Varieties
- Evogene Reports Fourth Quarter and Year End 2010 Financial Results
- Evogene Continues to Expand Its Scientific Team and Senior Recruitments
- Biogemma Advances Evogene's Yield and Drought Tolerance Trait in its Corn Development Pipeline